Nanostim, Inc., a privately-owned developer of miniaturized, leadless pacemakers, today announced that they have reached an agreement under which St. Jude Medical, Inc. STJ has committed to a staged financing of Nanostim, subject to the company achieving certain development and clinical
milestones. The agreement also gives St. Jude Medical the exclusive option to acquire the company.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in